Niki BioSolutions, Inc. Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent
Niki BioSolutions, Inc. (NIKI) reported Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent of -$1.38 million for the 12-month period ending 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Income Statement › Net Income
us-gaap:IncomeLossFromContinuingOperations · last filed 2026-05-11
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent 12 month |
|---|---|
| 2025-12-31 | -$1.38M S-4/A · filed 2026-05-11 |
| 2024-12-31 | -$4.16M S-4/A · filed 2026-05-11 |
| 2023-12-31 | -$4.34M S-4/A · filed 2026-05-11 |